ALEC
Alector, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.28
+11.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -33.90x
- Price / sales
- 24.38x
- Price / cash flow
- -2.14x
Enterprise value
- Enterprise value
- $198.0M
- EV / sales
- 14.28x
- EV / EBITDA
- -1.78x
- EV / EBIT
- -1.57x
- Market cap
- $338.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026